There is actually 70 m savings in operating expenses , so Mayne is operating both Nexstellis and TXMD at profit for the first time , so they are correct 14 m +ve contribution and international segment always making profit , hopefully they add more dermatology products from similar companies to use the existing sales force . Smart idea
- Forums
- ASX - By Stock
- MYX
- Ann: 2023 Full Year Results Investor Presentation
Ann: 2023 Full Year Results Investor Presentation, page-34
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.38 |
Change
-0.100(2.23%) |
Mkt cap ! $372.6M |
Open | High | Low | Value | Volume |
$4.45 | $4.53 | $4.38 | $514.8K | 116.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4744 | $4.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.40 | 168 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4744 | 4.380 |
3 | 9137 | 4.370 |
1 | 168 | 4.360 |
3 | 2318 | 4.350 |
1 | 168 | 4.340 |
Price($) | Vol. | No. |
---|---|---|
4.400 | 168 | 1 |
4.410 | 168 | 1 |
4.420 | 168 | 1 |
4.430 | 168 | 1 |
4.440 | 168 | 1 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |